Clinical Trials Directory

Trials / Completed

CompletedNCT01852084

Hydrophobic Acrylic Toric IOL Designed to Reduce the Effects of Preoperative Corneal Astigmatism

To Evaluate the Safety and Effectiveness of the EnVista® One-Piece Hydrophobic Acrylic Toric IOL Designed to Reduce the Effects of Preoperative Corneal Astigmatism on Postoperative Refraction Following Cataract Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
191 (actual)
Sponsor
Bausch & Lomb Incorporated · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigational enVista IOL, Model MX60Tis equipped with toric optics and axis marks on the posterior surface to minimize the possibility of surgically induced astigmatism.

Detailed description

The investigational enVista Toric IOL, Model MX60T, and the currently approved Model MX60, are identical with the exception of the addition of toric optics and axis marks on the posterior optic surface for the correction of astigmatism on the Model MX60T. Both lenses have an aspheric biconvex optic with a modified C haptic monoblock, single-piece design. The design and material of both the MX60 and MX60T allow them to be folded and inserted through small incisions to minimize the possibility of surgically induced astigmatism (SIA).

Conditions

Interventions

TypeNameDescription
DEVICEenVista® One-Piece Hydrophobic Acrylic Toric IOLTest lens having a toric cylinder power of either 1.25 diopters (D), 2.00 D, or 2.75 D
DEVICEenVista control lensSpherical Control lens

Timeline

Start date
2013-03-06
Primary completion
2016-07-18
Completion
2016-12-01
First posted
2013-05-13
Last updated
2020-09-16
Results posted
2020-09-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01852084. Inclusion in this directory is not an endorsement.